The challenge of ST-segment elevation myocardial infarction
1Division of Cardiology, Newark Beth Israel Medical Center, Newark, NJ 07112, USA.
Insights
ST-segment elevation myocardial infarction (STEMI) is a serious heart condition. Rapid diagnosis and timely reperfusion therapy, such as percutaneous coronary intervention (PCI), are crucial for improving patient survival and preventing further events.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- Acute coronary syndromes (ACS) encompass myocardial ischemic events with shared pathophysiology.
- ST-segment elevation myocardial infarction (STEMI) is a severe ACS form, posing a significant public health challenge with 500,000 annual US cases.
Purpose of the Study:
- To highlight the critical importance of early reperfusion therapy in STEMI management.
- To emphasize the need for improved protocols to expedite STEMI diagnosis and treatment initiation.
Main Methods:
- Review of current treatment guidelines for STEMI.
- Analysis of reperfusion strategies, including percutaneous coronary intervention (PCI) and fibrinolytic therapy.
- Discussion of adjunctive antithrombotic and antiplatelet agents.
Main Results:
- Early reperfusion therapy is paramount in STEMI treatment.
- Percutaneous coronary intervention (PCI) is the preferred reperfusion method.
- Antithrombotics and antiplatelet agents are vital adjuncts in acute STEMI care.
Conclusions:
- Patient survival hinges on rapid STEMI diagnosis and timely treatment.
- Current guidelines recommend PCI within 90 minutes and fibrinolytics within 30 minutes of presentation.
- A significant gap exists between recommended and actual reperfusion times, necessitating protocol improvements for faster intervention and secondary prevention strategies.
Background/Introduction:
Acute coronary syndromes (ACS) represent a spectrum of ischaemic myocardial events that share a similar pathophysiology. ST-segment elevation myocardial infarction (STEMI), the most severe form of ACS short of sudden cardiac death, is a significant public health problem with an estimated 500,000 STEMI events every year in the United States.
Treatment/Therapy:
The mortality and morbidity associated with STEMI is significant. Early reperfusion therapy is the most important aspect of the treatment of STEMI. There are two main methods of reperfusion therapy: percutaneous coronary intervention (PCI) and fibrinolytic therapy, with PCI being the preferred method. In addition to standard reperfusion therapy, antithrombotics (unfractionated heparin and low molecular weight heparins) and antiplatelet agents (aspirin, clopidogrel and glycoprotein IIb/IIIa inhibitors) are critical adjuncts, effective in the treatment of acute STEMI.
Conclusions:
The survival of patients with STEMI depends on rapid diagnosis and optimal early treatment. Guidelines for the management of patients with STEMI recommend PCI within 90 min of presentation and that fibrinolytics are administered within 30 min. However, only a fraction of patients undergo reperfusion within the recommended time. Improvements in protocols for identifying STEMI cases are therefore required to allow reperfusion therapy to be initiated sooner. Secondary prevention is another important aspect of STEMI management, and patients should be encouraged to adopt strategies that reduce the risk of subsequent ischaemic events.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:26Transient Ischemic Attack l: Introduction
01:15Ischemic Stroke l: Introduction